Company / Cash per Share
Aurinia Pharmaceuticals Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.57
FY2025
5-year range
$0.34 / $2.44
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#164 of 205
Health Care
What the data says
Aurinia Pharmaceuticals Inc.'s cash per share of $0.57 is lower than 80% of companies in the Health Care sector (FY2025). Improved from $0.34 to $0.57 over the past 2 years.
Based on SEC 10-K filings.
0.57 in FY2025 with a 5-year CAGR of -29.1%.
Improved from $0.34 to $0.57 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -32.2%
- 5-Year CAGR
- -29.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 205This company $0.57 Sector average $67.98
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 1.9% year-over-year.
- Ranks #164 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | -1.9% |
| FY2024 | $0.58 | +68.4% |
| FY2023 | $0.34 | -81.2% |
| FY2022 | $1.83 | -24.9% |
| FY2021 | $2.44 | -23.5% |
| FY2020 | $3.19 | -3.2% |
| FY2019 | $3.29 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026